The Twenty Minute VCWe Built Our Own Salesforce in Months. Here's Why We're Cancelling the $600K Contract | Curative CEO
At a glance
WHAT IT’S REALLY ABOUT
Curative’s whiplash pivots: COVID scale, insurer reinvention, AI overhaul
- Turner traces a founder journey of repeated pivots—cattle genomics to human diagnostics to sepsis—before a near-death shutdown set the stage for Curative’s COVID testing break out.
- Curative seized early-pandemic testing demand by rapidly acquiring lab capability, winning government contracts, and scaling to 206,000 tests/day and ~7,000 employees in nine months.
- The COVID business produced $5B in revenue but had volatile economics—highly profitable during surges, loss-making during demand lulls due to fixed capacity requirements.
- As COVID demand faded, Curative chose health insurance as the next giant market, arguing payers drive healthcare behavior and consolidation makes current negotiations inefficient.
- Turner claims AI agents are eliminating or radically shrinking insurance back-office work and enabling major SaaS replacement, while raising new questions about labor displacement and governance.
IDEAS WORTH REMEMBERING
5 ideasMarket size can force the right pivot faster than technology can.
The cow-testing business hit a Series A ceiling once investors did the TAM math, pushing the team to reuse core DNA testing capabilities in larger human-health markets.
Sepsis innovation fails if workflows don’t trigger the test in time.
Turner argues community hospitals often don’t suspect sepsis early enough, so better diagnostics alone don’t improve outcomes unless operational adoption is solved.
In crises, scaling requires abandoning “efficient” industry defaults.
Curative outscaled incumbents by rebuilding the testing stack for 10× demand and using an “orthogonal supply chain” (alternative consumables, filter plates over magnetic beads) rather than competing for the same constrained inputs.
Government contract structure can become your financing mechanism.
LA’s daily invoicing with next-day checks and other large public contracts provided the cash flow that enabled rapid expansion and even funded a $27M lab buyout via forward revenue.
Pandemic businesses can be huge yet structurally unstable.
Testing economics swung from strong margins at peak utilization to losses in troughs because capacity had to stay staffed and ready for the next surge.
WORDS WORTH SAVING
5 quotesAnd the company went from about seven to 7,000 employees in, in those first nine months.
— Fred Turner
I sold that license to a company in San Diego for $150,000, uh, to pay some of the creditors. And then five months later, acquired a company in Southern California to get the same license for 27 million. So timing is everything.
— Fred Turner
So we built what we called, uh, an orthogonal supply chain, which is just basically a fancy way of saying, we don't use the things other people use.
— Fred Turner
We have now built in-house an agent that runs on, on Claude that does this end to end... we're now averaging about 12 hours turnaround time for credentialing somebody, and it costs us about 20 cents.
— Fred Turner
I think today the current gen models can do every back office task we have at Curative. It's just a matter of deploying them, like getting them set up, getting them configured, having the right policies.
— Fred Turner
High quality AI-generated summary created from speaker-labeled transcript.
